Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry.
Mateo Marin-CuartasGilbert H L TangPhilipp KieferShinichi FukuharaRudiger LangeKatherine B HarringtonShekhar SahaChristian HaglNeal S KleimanSachin S GoelJoerg KempfertPaul WernerGeorge A PetrossianArnar GeirssonNimesh D DesaiMichael W A ChuOliver D BhadraChristian ShultsAndrea GarattiFlavien VincentKendra J GrubbJoshua B GoldbergMichael J MackThomas ModinePaolo DentiTsuyoshi KanekoVinayak N BapatMichael J ReardonMichael A BorgerSyed Zaidnull nullPublished in: European heart journal (2024)
In the EXPLANT-TAVR registry, patients undergoing THV explant for IE had higher 30-day and 1-year stroke rates and longer intensive care unit and hospital stays. Moreover, patients undergoing THV explant for IE had a higher 3-year mortality rate, which did not reach statistical significance given the relatively small sample size of this unique cohort and the reduced number of events.
Keyphrases
- patients undergoing
- aortic valve
- intensive care unit
- transcatheter aortic valve replacement
- aortic stenosis
- atrial fibrillation
- heart failure
- healthcare
- mitral valve
- risk factors
- cardiovascular disease
- emergency department
- coronary artery disease
- type diabetes
- mechanical ventilation
- left ventricular
- insulin resistance
- skeletal muscle
- brain injury